Countering the problem of falsified and substandard drugs /

Afficher d'autres versions (1)

"The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a M...

Description complète

Détails bibliographiques
Cote:Libro Electrónico
Collectivité auteur: Institute of Medicine (U.S.). Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products (Auteur)
Autres auteurs: Buckley, Gillian J. (Éditeur intellectuel), Gostin, Lawrence O. (Lawrence Ogalthorpe) (Éditeur intellectuel)
Format: Électronique eBook
Langue:Inglés
Publié: Washington, D.C. : National Academies Press, [2013]
Sujets:
Pharmaceutical industry.
Pharmaceutical industry > Quality control.
Fraud > Prevention.
Quality control.
International cooperation.
Counterfeit Drugs
Fraud > prevention & control
Drug Contamination > prevention & control
Pharmaceutical Preparations > standards
Quality Control
International Cooperation
Drug Industry
Industrie pharmaceutique > Qualité > Contrôle.
Industrie pharmaceutique.
Qualité > Contrôle.
Coopération internationale.
quality control.
BUSINESS & ECONOMICS > Industries > General.
Quality control
International cooperation
Fraud > Prevention
Pharmaceutical industry
Pharmaceutical industry > Quality control
Accès en ligne:Texto completo
Table des matières:
  • Introduction
  • The effects of falsified and substandard drugs
  • The magnitude of the problem
  • Causes of falsified and substandard drugs
  • Weaknesses in the drug distribution chain
  • Detection technology
  • An international code of practice for falsified and substandard medicines.

Documents similaires